ISRCTN70703138已完成不适用
Effect of therapy on residual beta cell function in type-1 diabetes mellitus
Justus Liebig University (Germany)0 个研究点目标入组 0 人开始时间: 2002年10月3日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Men or women aged 18 - 40 years at diagnosis
- •2. Established Type-1 Diabetes diagnosed up to three months ago
- •3. Consent to participate in a diabetes training programme
- •4. Informed consent before enrolment
排除标准
- •1. History of neuropathy, nephropathy, and retinopathy of other than diabetes related origin
- •2. Negative C-peptide level at diagnosis
- •3. History of psychiatric disease or drug or alc ohol abuse
- •4. Treatment with oral antidiabetic medication
- •5. Subject unlikely to comply with the protocol (e.g. inability or unwillingness to participate adequate training or to complete diaries appropriately) or to understand the nature and the scope of the study
研究者
相似试验
招募中
Unknown
A multicenter trial on the effects of oral hypoglycemic agents on beta-cell function in drug-naive type 2 diabetesType 2 DiabetesJPRN-jRCTs051220187Furukawa Yasushi87
尚未招募
不适用
A retrospective study on beta cell function in type 2 diabetic patients using GLP-1 receptor agonistType 2 diabetes mellitusJPRN-UMIN000031697Showa University of medicine, the department of internal medicine, the division of diabetology, metabolism and endocrinology60
已完成
不适用
Do the remaining insulin-producing cells in people with type 1 diabetes help to maintain good glucose control after exercise?Nutritional, Metabolic, EndocrineType 1 diabetesISRCTN50072340ewcastle University30
已完成
不适用
Study on association between beta cell function and glycemic variability in the non-diabetic subjects with normal glucose tolerance and impaired glucose tolerancediabetesJPRN-UMIN000020002Kobe University Graduate School of Medicine100
招募中
不适用
Investigation of beta-cell function by receiving semaglutide among inpatints with type 2 diabetes.type2 diabetesJPRN-UMIN000042478Saiseikai Yokohamashi Nanbu Hospital80
